Benchling Introduces Bioprocess Cloud and Validated GxP Workflows for Cell and Gene Therapy CMC
August 26, 2026 • Source: BioSpace
Benchling expanded its R&D Cloud into downstream Chemistry, Manufacturing, and Controls (CMC) with Benchling Bioprocess and automated FDA 21 CFR Part 11 validation packages.
**Executive Summary (2026-08-26):** Benchling expanded its R&D Cloud into downstream Chemistry, Manufacturing, and Controls (CMC) with Benchling Bioprocess and automated FDA 21 CFR Part 11 validation packages. Source: BioSpace.
Technical Architecture & R&D Impact
The release connects early discovery construct design directly to upstream fermentation, downstream purification, and analytical quality testing, eliminating manual Excel data handoffs between discovery and process development teams.
Enterprise Biopharma Procurement Takeaways
For computational biology leads, medicinal chemists, and R&D IT architects, this milestone underscores the rapid convergence of wet-lab experimental validation and scalable cloud foundation models during H2 2026. Teams evaluating vendors in the Update category should benchmark API reproducibility, GxP audit readiness, and zero-data-retention VPC deployment terms.
Related Products
Published August 26, 2026
More NewsLast updated: August 26, 2026
